ArticleJournal of diabetes investigation2026

Do the treatment selection factors emphasized in clinical guidelines-Chronic kidney disease, cardiovascular disease, and heart failure-contribute to the risk of urinary tract infections during the administration of sodium-glucose cotransporter-2 inhibitors?

Takuma Koinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.